Drug
Tasisulam clinical trials
Also written LY573636.
Includes 8 studies of Tasisulam sodium.
- studies test it
- 12
- open now
- 0
- in phase 3
- 1
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 5
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Pemetrexed (1) · Sunitinib (1) · Liposomal doxorubicin (1) · Doxorubicin (1) · Midazolam (1) · Tolbutamide (1)
Studies
Open first, then newest update. How each study uses tasisulam is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue SarcomaCompletedPhase 2Eli Lilly and CompanyNCT00490451Written as LY573636-sodium
- A Tasisulam and Midazolam Drug Interaction Study in Cancer PatientsTerminatedPhase 1Eli Lilly and CompanyNCT01209832Written as Tasisulam
- A Phase 1 Study in Patients With Solid TumorsCompletedPhase 1Eli Lilly and CompanyNCT01215916Written as LY573636
- A Phase 1b Trial in Patients With Renal Cell CancerCompletedPhase 1Eli Lilly and CompanyNCT01258348Written as Drug: LY573636-sodium
- Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid LeukemiaCompletedPhase 1Eli Lilly and CompanyNCT00718159Written as LY573636-sodium
- Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid TumorsCompletedPhase 1Eli Lilly and CompanyNCT01214668Written as LY573636-sodium
- Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung CancerCompletedPhase 2Eli Lilly and CompanyNCT00363766Written as LY573636-sodium
- A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or LymphomaTerminatedPhase 1Eli Lilly and CompanyNCT01185548Written as Tasisulam
- A Study of LY573636-sodium in Patients With Metastatic Breast CancerCompletedPhase 2Eli Lilly and CompanyNCT00992225Written as LY573636-sodium
- A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaTerminatedPhase 3Eli Lilly and CompanyNCT01006252Written as Tasisulam-sodium
- A Study of Tasisulam in Treating Participants With Malignant MelanomaCompletedPhase 2Eli Lilly and CompanyNCT00383292Written as tasisulam
- A Study of Chemotherapy Treatment for Patients With Ovarian CancerCompletedPhase 2Eli Lilly and CompanyNCT00428610Written as LY573636-sodium
Given in every arm · 1 — tasisulam is usual care beside what is tested
Codes
What other systems call tasisulam · ClinicalTrials.gg INT005373
- UNII (FDA) 1YC4W9MSLJTASISULAMConfirmed FDA, Wikidata
- Wikidata Q27253184tasisulamConfirmed FDA, Wikidata
- NCI Thesaurus C62794TasisulamOne source FDA
- DrugBank DB11941One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1YC4W9MSLJ | TASISULAM | Confirmed FDA, Wikidata |
| Wikidata | Q27253184 | tasisulam | Confirmed FDA, Wikidata |
| NCI Thesaurus | C62794 | Tasisulam | One source FDA |
| DrugBank | DB11941 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.